Log In
Print this Print this

Birch pollen vaccine

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionVaccine containing genetically modified recombinant Betv1 fragments
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat allergy
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today